Cargando…
Impact of Glycosylation on Effector Functions of Therapeutic IgG †
Human IgG has only one conserved glycosylation site located in the Cγ2 domain of the Fc region that accounts for the presence of two sugar moieties per IgG. These IgG sugar cores play a critical role in a number of IgG effector functions. In the present review, we describe the main characteristics o...
Autores principales: | Abès, Riad, Teillaud, Jean-Luc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991024/ https://www.ncbi.nlm.nih.gov/pubmed/27713246 http://dx.doi.org/10.3390/ph3010146 |
Ejemplares similares
-
In Response to: ‘Impact of Glycosylation on Effector Functions of Therapeutic IgG’ (Pharmaceuticals 2010, 3, 146–157)
por: Nechansky, Andreas, et al.
Publicado: (2010) -
The Ligands for Human IgG and Their Effector Functions
por: de Taeye, Steven W., et al.
Publicado: (2019) -
Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy
por: Mimura, Yusuke, et al.
Publicado: (2017) -
IgG Fc engineering to modulate antibody effector functions
por: Wang, Xinhua, et al.
Publicado: (2017) -
Principles of N-Linked Glycosylation Variations of IgG-Based Therapeutics: Pharmacokinetic and Functional Considerations
por: Boune, Souad, et al.
Publicado: (2020)